Medizia Biotech is a leading global pharmaceutical company specializing in the development of innovative injectable formulations. Certified by WHO-GMP, ISO 9001:2015, and DCGI, we offer third-party manufacturing and PCD pharma franchise opportunities for intensive care products in both domestic and international markets. Our diverse product range includes Critical Care Antibiotic Injections, Gastroenterology Injections, Cardiology Injections, Anti-malarials, Analgesics, and NSAID Injections, all manufactured under strict WHO GMP guidelines.

Our state-of-the-art manufacturing unit employs modern processing techniques and high-grade chemical compounds, adhering to stringent medical industry standards. Our Quality Control and Analytical Research Laboratory ensures our products meet the highest domestic and international standards, offering reliability and consistency.

At Medizia Biotech, our values and expectations drive our culture and operations, making us a preferred partner in the pharma industry. We prioritize consumer satisfaction and maintain an extensive range of critical care products. Our commitment to quality and excellence has positioned us as a leading pharma company and service provider in India.

Choosing Medizia Biotech as your partner comes with numerous advantages:

Unmatched Quality & Compliance:
Our advanced manufacturing facility adheres to stringent industry standards, ensuring high-quality and safe products.

Business Standards:
Our skilled professionals ensure adherence to GMP standards, consistently delivering excellent results.

Exclusive Product Range:
Our diverse pharmaceutical portfolio allows franchise partners to meet various healthcare needs and maximize business potential.

Competitive Pricing & Support:
We offer competitive pricing, extensive marketing materials, and robust support to help our partners succeed.

Our goal is to discover, develop, and provide innovative products that improve lives, making Medizia Biotech a brilliant place to work and partner with.